58 related articles for article (PubMed ID: 8714227)
21. A novel arterial infusion chemotherapy for the treatment of patients with advanced pancreatic carcinoma after vascular supply distribution via superselective embolization.
Homma H; Doi T; Mezawa S; Takada K; Kukitsu T; Oku T; Akiyama T; Kusakabe T; Miyanishi K; Niitsu Y
Cancer; 2000 Jul; 89(2):303-13. PubMed ID: 10918160
[TBL] [Abstract][Full Text] [Related]
22. Effect of different treatment methods on survival in patients with pancreatic cancer.
Brasiūniene B; Juozaityte E; Inciūra A; Brasiūnas V; Barauskas G
Rocz Akad Med Bialymst; 2003; 48():66-9. PubMed ID: 14737944
[TBL] [Abstract][Full Text] [Related]
23. Hepatic transcatheter arterial chemoembolization alternating with systemic protracted continuous infusion 5-fluorouracil for gastrointestinal malignancies metastatic to liver: a phase II trial of the Puget Sound Oncology Consortium (PSOC 1104).
Bavisotto LM; Patel NH; Althaus SJ; Coldwell DM; Nghiem HV; Thompson T; Storer B; Thomas CR
Clin Cancer Res; 1999 Jan; 5(1):95-109. PubMed ID: 9918207
[TBL] [Abstract][Full Text] [Related]
24. Adjuvant regional chemotherapy in advanced pancreatic cancer: results of a prospective study.
Beger HG; Link KH; Gansauge F
Hepatogastroenterology; 1998; 45(21):638-43. PubMed ID: 9684109
[TBL] [Abstract][Full Text] [Related]
25. [A new regional arterial infusion chemotherapy for patients with advanced pancreatic cancer].
Homma H; Niitsu Y
Gan To Kagaku Ryoho; 2002 Mar; 29(3):383-9. PubMed ID: 11915727
[TBL] [Abstract][Full Text] [Related]
26. Adenocarcinoma of the pancreatic head: a community teaching hospital's experience from 1982 to 1992.
Falk J; Keidan R; Rigo PK; Dmuchowski C
Am Surg; 1999 Jan; 65(1):15-8. PubMed ID: 9915524
[TBL] [Abstract][Full Text] [Related]
27. [Hepatic and splenic arterial infusion chemotherapy after transcatheter peripancreatic arterial embolization for patients with inoperable adenocarcinoma of the pancreas].
Homma H; Kukitsu T; Mezawa S; Doi T; Kida M; Miyanishi K; Takada K; Murase K; Iyama S; Niitsu Y
Gan To Kagaku Ryoho; 2001 Oct; 28(11):1558-61. PubMed ID: 11707979
[TBL] [Abstract][Full Text] [Related]
28. Repetitive chemoembolization with melphalan plus intra-arterial immuno-chemotherapy within 5-fluorouracil and granulocyte-macrophage colony-stimulating factor (GM-CSF) as effective first- and second-line treatment of disseminated colorectal liver metastases.
Müller H; Nakchbandi V; Chatzisavvidis I; von Voigt C
Hepatogastroenterology; 2003; 50(54):1919-26. PubMed ID: 14696433
[TBL] [Abstract][Full Text] [Related]
29. Surgery and multimodal treatments in pancreatic cancer--a review on the basis of future multimodal treatment concepts.
Link KH; Leder G; Formentini A; Fortnagel G; Kornmann M; Schatz M; Beger HG
Gan To Kagaku Ryoho; 1999 Jan; 26(1):10-40. PubMed ID: 9987495
[TBL] [Abstract][Full Text] [Related]
30. Treatment of abdominal malignant neoplasms using regional chemotherapy with hemofiltration.
Muchmore JH; Krementz ET; Carter RD; Preslan JE; George WJ
Arch Surg; 1991 Nov; 126(11):1390-6. PubMed ID: 1747052
[TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetics of mitomycin C in pelvic stopflow infusion and hypoxic pelvic perfusion with and without hemofiltration: a pilot study of patients with recurrent unresectable rectal cancer.
Guadagni S; Aigner KR; Palumbo G; Cantore M; Fiorentini G; Pozone T; Deraco M; Clerico M; Chaudhuri PK
J Clin Pharmacol; 1998 Oct; 38(10):936-44. PubMed ID: 9807975
[TBL] [Abstract][Full Text] [Related]
32. Isolated hypoxic perfusion with mitomycin C in patients with advanced pancreatic cancer.
Lorenz M; Petrowsky H; Heinrich S; Janshon G; Staib-Sebler E; Poloczek Y; Gog C; Oremek G; Encke A
Eur J Surg Oncol; 1998 Dec; 24(6):542-7. PubMed ID: 9870731
[TBL] [Abstract][Full Text] [Related]
33. Isolated hypoxic perfusion with mitomycin C in patients with advanced pancreatic cancer.
Guadagni S
Eur J Surg Oncol; 1999 Jun; 25(3):339-40. PubMed ID: 10336818
[No Abstract] [Full Text] [Related]
34. Iodine-125 seed implantation combined chemotherapy for metastatic pancreatic adenocarcinoma with primary colon cancer: A case report.
Song Y; Qi Y; Yu Z; Zhang Z; Li Y; Huang J; Liu S
Medicine (Baltimore); 2022 Sep; 101(36):e30349. PubMed ID: 36086719
[TBL] [Abstract][Full Text] [Related]
35. Immunotherapy, advanced cancer, and hyposplenism.
Hochhuth HF
Ann Intern Med; 1987 Aug; 107(2):258. PubMed ID: 3605911
[No Abstract] [Full Text] [Related]
36. Regional Therapies for Advanced Cancer: Update for 2016.
Turaga KK; Gamblin TC; Alexander HR; Edwards R; Bartlett DL
Ann Surg Oncol; 2016 May; 23(5):1452-3. PubMed ID: 26732273
[No Abstract] [Full Text] [Related]
37. Gemcitabine-Based Regional Intra-Arterial Infusion Chemotherapy in Patients With Advanced Pancreatic Adenocarcinoma.
Liu X; Yang X; Zhou G; Chen Y; Li C; Wang X
Medicine (Baltimore); 2016 Mar; 95(11):e3098. PubMed ID: 26986149
[TBL] [Abstract][Full Text] [Related]
38. Marginal effects of regional intra-arterial chemotherapy as an alternative treatment option in advanced pancreatic carcinoma.
Meyer F; Grote R; Lippert H; Ridwelski K
Langenbecks Arch Surg; 2004 Feb; 389(1):32-9. PubMed ID: 14655016
[TBL] [Abstract][Full Text] [Related]
39. Celiac axis infusion chemotherapy in advanced nonresectable pancreatic cancer.
Maurer CA; Borner MM; Läuffer J; Friess H; Z'graggen K; Triller J; Büchler MW
Int J Pancreatol; 1998 Jun; 23(3):181-6. PubMed ID: 9629517
[TBL] [Abstract][Full Text] [Related]
40. Regional chemotherapy with hemofiltration: a rationale for a different treatment approach to advanced pancreatic cancer.
Muchmore JH; Carter RD; Preslan JE; George WJ
Hepatogastroenterology; 1996; 43(8):346-55. PubMed ID: 8714227
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
